The pahtway p641 has 65 genes in the original annotation. Currently, there are 46 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
23411 | SIRT1 | SIR2 | SIR2L1 | SIR2alpha | sirtuin 1 | | | 10q21.3 |
6688 | SPI1 | OF | PU.1 | SFPI1 | SPI-1 | SPI-A | Spi-1 proto-oncogene | | | 11p11.2 |
4654 | MYOD1 | MYF3 | MYOD | PUM | bHLHc1 | myogenic differentiation 1 | | | 11p15.4 |
595 | CCND1 | BCL1 | D11S287E | PRAD1 | U21B31 | cyclin D1 | | | 11q13 |
894 | CCND2 | KIAK0002 | MPPH3 | cyclin D2 | | | 12p13 |
1027 | CDKN1B | CDKN4 | KIP1 | MEN1B | MEN4 | P27KIP1 | cyclin-dependent kinase inhibitor 1B | | | 12p13.1-p12 |
11016 | ATF7 | ATFA | activating transcription factor 7 | | | 12q13 |
1019 | CDK4 | CMM3 | PSK-J3 | cyclin-dependent kinase 4 | | | 12q14 |
4193 | MDM2 | ACTFS | HDMX | hdm2 | MDM2 proto-oncogene | | | 12q14.3-q15 |
5925 | RB1 | OSRC | PPP1R130 | RB | p105-Rb | pRb | pp110 | retinoblastoma 1 | | | 13q14.2 |
7027 | TFDP1 | DILC | DP1 | DRTF1 | Dp-1 | transcription factor Dp-1 | | | 13q34 |
145258 | GSC | SAMS | goosecoid homeobox | | | 14q32.1 |
1387 | CREBBP | CBP | KAT3A | RSTS | CREB binding protein | | | 16p13.3 |
26574 | AATF | BFR2 | CHE-1 | CHE1 | DED | apoptosis antagonizing transcription factor | | | 17q12 |
7343 | UBTF | NOR-90 | UBF | UBF-1 | UBF1 | UBF2 | upstream binding transcription factor, RNA polymerase I | | | 17q21.31 |
1786 | DNMT1 | ADCADN | AIM | CXXC9 | DNMT | HSN1E | MCMT | m.HsaI | DNA (cytosine-5-)-methyltransferase 1 | | | 19p13.2 |
6597 | SMARCA4 | BAF190 | BAF190A | BRG1 | MRD16 | RTPS2 | SNF2 | SNF2L4 | SNF2LB | SWI2 | hSNF2b | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | | | 19p13.2 |
898 | CCNE1 | CCNE | pCCNE1 | cyclin E1 | | | 19q12 |
1050 | CEBPA | C/EBP-alpha | CEBP | CCAAT/enhancer binding protein alpha | | | 19q13.1 |
3065 | HDAC1 | GON-10 | HD1 | RPD3 | RPD3L1 | histone deacetylase 1 | | | 1p34 |
1870 | E2F2 | E2F-2 | E2F transcription factor 2 | | | 1p36 |
2033 | EP300 | KAT3B | RSTS2 | p300 | E1A binding protein p300 | | | 22q13.2 |
5600 | MAPK11 | P38B | P38BETA2 | PRKM11 | SAPK2 | SAPK2B | p38-2 | p38Beta | mitogen-activated protein kinase 11 | | | 22q13.33 |
1386 | ATF2 | CRE-BP1 | CREB-2 | CREB2 | HB16 | TREB7 | activating transcription factor 2 | | | 2q32 |
5077 | PAX3 | CDHS | HUP2 | WS1 | WS3 | paired box 3 | | | 2q35 |
4286 | MITF | CMM8 | MI | WS2 | WS2A | bHLHe32 | microphthalmia-associated transcription factor | | | 3p13 |
5468 | PPARG | CIMT1 | GLM1 | NR1C3 | PPARG1 | PPARG2 | PPARgamma | peroxisome proliferator activated receptor gamma | | | 3p25 |
5894 | RAF1 | CMD1NN | CRAF | NS5 | Raf-1 | c-Raf | Raf-1 proto-oncogene, serine/threonine kinase | | | 3p25 |
1487 | CTBP1 | BARS | C-terminal binding protein 1 | | | 4p16 |
6502 | SKP2 | FBL1 | FBXL1 | FLB1 | p45 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | | | 5p13 |
4208 | MEF2C | C5DELq14.3 | DEL5q14.3 | myocyte enhancer factor 2C | | | 5q14.3 |
8841 | HDAC3 | HD3 | RPD3 | RPD3-2 | histone deacetylase 3 | | | 5q31 |
5515 | PPP2CA | PP2Ac | PP2CA | PP2Calpha | RP-C | protein phosphatase 2 catalytic subunit alpha | | | 5q31.1 |
1437 | CSF2 | GMCSF | colony stimulating factor 2 | | | 5q31.1 |
860 | RUNX2 | AML3 | CBF-alpha-1 | CBFA1 | CCD | CCD1 | CLCD | OSF-2 | OSF2 | PEA2aA | PEBP2aA | runt related transcription factor 2 | | | 6p21 |
896 | CCND3 | - | cyclin D3 | | | 6p21 |
1026 | CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A | | | 6p21.2 |
6046 | BRD2 | D6S113E | FSH | FSRG1 | NAT | O27.1.1 | RING3 | RNF3 | bromodomain containing 2 | | | 6p21.3 |
1432 | MAPK14 | CSBP | CSBP1 | CSBP2 | CSPB1 | EXIP | Mxi2 | PRKM14 | PRKM15 | RK | SAPK2A | p38 | p38ALPHA | mitogen-activated protein kinase 14 | | | 6p21.3-p21.2 |
1871 | E2F3 | E2F-3 | E2F transcription factor 3 | | | 6p22 |
6908 | TBP | GTF2D | GTF2D1 | HDL4 | SCA17 | TFIID | TATA-box binding protein | | | 6q27 |
1021 | CDK6 | MCPH12 | PLSTIRE | cyclin-dependent kinase 6 | | | 7q21-q22 |
1052 | CEBPD | C/EBP-delta | CELF | CRP3 | NF-IL6-beta | CCAAT/enhancer binding protein delta | | | 8p11.2-p11.1 |
1029 | CDKN2A | ARF | CDK4I | CDKN2 | CMM2 | INK4 | INK4A | MLM | MTS-1 | MTS1 | P14 | P14ARF | P16 | P16-INK4A | P16INK4 | P16INK4A | P19 | P19ARF | TP16 | cyclin-dependent kinase inhibitor 2A | | | 9p21 |
25 | ABL1 | ABL | JTK7 | bcr/abl | c-ABL | c-ABL1 | p150 | v-abl | ABL proto-oncogene 1, non-receptor tyrosine kinase | | | 9q34.1 |
6872 | TAF1 | BA2R | CCG1 | CCGS | DYT3 | DYT3/TAF1 | KAT4 | MRXS33 | N-TAF1 | NSCL2 | OF | P250 | TAF(II)250 | TAF2A | TAFII-250 | TAFII250 | XDP | TATA-box binding protein associated factor 1 | | | Xq13.1 |